AMBRA1 and loricrin as a test to identify low-risk early-stage melanoma

Br J Dermatol. 2024 Mar 15;190(4):e46. doi: 10.1093/bjd/ljae078.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adaptor Proteins, Signal Transducing
  • Biomarkers
  • Humans
  • Melanoma* / diagnosis
  • Melanoma, Cutaneous Malignant
  • Membrane Proteins*
  • Prognosis
  • Skin Neoplasms* / diagnosis
  • United States

Substances

  • loricrin
  • Biomarkers
  • AMBRA1 protein, human
  • Adaptor Proteins, Signal Transducing
  • Membrane Proteins